首页> Vaccine> Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Joon Young,Song

第一单位： Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; Transgovernmental Enterprise for Pandemic Influenza in Korea, Seoul, Republic of Korea.

作者： Joon Young,Song ^[1] ; Hee Jin,Cheong ^[2] ; Jacob,Lee ^[3] ; Heung Jeong,Woo ^[3] ; Seong-Heon,Wie ^[4] ; Jin-Soo,Lee ^[5] ; Shin Woo,Kim ^[6] ; Ji Yun,Noh ^[1] ; Won Suk,Choi ^[2] ; Hun,Kim ^[7] ; Kyung-Ho,Kim ^[7] ; Woo Joo,Kim ^[8]

作者单位： Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; Transgovernmental Enterprise for Pandemic Influenza in Korea, Seoul, Republic of Korea. ^[1] Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. ^[2] Hallym University College of Medicine, Seoul, Republic of Korea. ^[3] St. Vincent's Hospital, Catholic University of Korea College of Medicine, Suwon, Gyeonggi-do, Republic of Korea. ^[4] Inha University College of Medicine, Incheon, Republic of Korea. ^[5] Kyungpook National University School of Medicine, Daegu, Republic of Korea. ^[6] Life Science Research Institute, SK Chemicals, Seongnam, Gyeonggi-do, Republic of Korea. ^[7] Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; Transgovernmental Enterprise for Pandemic Influenza in Korea, Seoul, Republic of Korea. Electronic address: wjkim@korea.ac.kr. ^[8]

关键词 Cell culture techniques Human Inactivated Influenza Influenza vaccines Vaccines